Physician profile
Bryan Keith Scott
NPI 1558858456
$14,872.57
in general payments reported to CMS, 2019-2025
23 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $604 · 2020: $1,105 · 2021: $269 · 2022: $2,830 · 2023: $4,662 · 2024: $5,239 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,388 · Travel and Lodging: $4,677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,387.82 |
| Travel and Lodging | $4,677.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $11,996.44 | 2021-2025 | Hoffmann, Prostep, Inbone |
| Southern Edge Orthopaedics, INC. | $1,708.96 | 2019-2020 | |
| Smith+Nephew, INC. | $180.27 | 2021-2023 | Regranex, Collagenase Santyl |
| Ossio INC | $155.30 | 2022 | |
| Kerecis Limited | $150.10 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Paratek Pharmaceuticals, INC. | $121.82 | 2021-2023 | Nuzyra |
| Fortis Surgical, LLC | $91.35 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $68.33 | 2022-2023 | Seglentis |
| Nevro Corp. | $48.23 | 2022-2023 | Senza |
| Depuy Synthes Sales INC. | $45.46 | 2022 | |
| Lifenet Health | $44.46 | 2023 | |
| Boston Scientific Corporation | $34.06 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Organogenesis INC. | $29.12 | 2022 | |
| Medtronic, INC. | $24.52 | 2024 | Intellis Adaptivestim |
| Abbott Laboratories | $23.77 | 2023 | Proclaim |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $23.26 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $22.12 | 2021 | |
| Integra Lifesciences Corporation | $19.44 | 2022 | |
| Fidia Pharma USA INC. | $18.57 | 2022 | |
| Medela LLC | $17.69 | 2022 | |
| Sebela Pharmaceuticals INC. | $17.41 | 2022 | |
| Convatec INC. | $15.96 | 2023 | |
| Mimedx Group, INC. | $15.93 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.